🧬
Biyoteknoloji Sektörü Hisseleri
Biyoteknoloji Sektörü altında 522 Hisse Senedi
Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
Biyoteknoloji Sektörü Hakkında
Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.
Temel Özellikler
- Yüksek AR-GE yatırımları
- Uzun geliştirme süreçleri
- Düzenleyici onay riskleri
- Yüksek büyüme potansiyeli
Önemli Şirketler
ModernaGilead SciencesBiogenRegeneron
522
Toplam Hisse
$2.5T
Toplam Piyasa Değeri
Biyoteknoloji Sektörü Hisseleri
Sayfa 1/6 (Toplam: 522)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | $680.94B | $737.67 | 2.09% | |
| ABBV | AbbVie Inc. | $332.08B | $186.11 | 0.26% | |
| MRK | Merck & Co., Inc. | $187.27B | $76.84 | 0.58% | |
| AMGN | Amgen Inc. | $145.42B | $288.18 | 1.64% | |
| PFE | Pfizer Inc. | $125.58B | $23.49 | 0.17% | |
| GILD | Gilead Sciences, Inc. | $124.54B | $110.08 | 0.93% | |
| VRTX | Vertex Pharmaceuticals Incorporated | $108.79B | $442.05 | 1.13% | |
| BMY | Bristol-Myers Squibb Company | $94.81B | $48.28 | 0.90% | |
| ZTS | Zoetis Inc. | $68.82B | $168.63 | 0.89% | |
| REGN | Regeneron Pharmaceuticals, Inc. | $60.44B | $490.28 | 19.01% | |
| IDXX | IDEXX Laboratories, Inc. | $40.97B | $513.36 | 0.42% | |
| ALNY | Alnylam Pharmaceuticals, Inc. | $34.80B | $304.56 | 3.98% | |
| PODD | Insulet Corporation | $22.43B | $325.03 | 0.36% | |
| NTRA | Natera, Inc. | $20.57B | $157.73 | 0.20% | |
| BIIB | Biogen Inc. | $18.05B | $129.79 | 2.23% | |
| ITCI | Intra-Cellular Therapies, Inc. | $14.05B | $131.87 | 0.00% | |
| ILMN | Illumina, Inc. | $12.56B | $82.24 | 2.42% | |
| EXEL | Exelixis, Inc. | $12.15B | $43.04 | 1.03% | |
| INSM | Insmed Incorporated | $11.92B | $69.73 | 0.75% | |
| NBIX | Neurocrine Biosciences, Inc. | $11.77B | $123.02 | 0.52% | |
| INCY | Incyte Corporation | $11.72B | $65.06 | 1.48% | |
| PEN | Penumbra, Inc. | $11.54B | $266.97 | 0.54% | |
| BMRN | BioMarin Pharmaceutical Inc. | $11.46B | $58.07 | 0.82% | |
| EXAS | Exact Sciences Corporation | $9.93B | $56.28 | 2.33% | |
| VTRS | Viatris Inc. | $9.92B | $8.79 | 0.45% | |
| MRNA | Moderna, Inc. | $9.46B | $26.56 | 1.37% | |
| MEDP | Medpace Holdings, Inc. | $8.47B | $294.90 | 0.72% | |
| TECH | Bio-Techne Corporation | $7.56B | $48.40 | 0.14% | |
| CORT | Corcept Therapeutics Incorporated | $7.53B | $77.56 | 0.10% | |
| RVMD | Revolution Medicines, Inc. | $7.37B | $39.40 | 0.81% | |
| RGEN | Repligen Corporation | $7.19B | $118.07 | 3.47% | |
| BIO | Bio-Rad Laboratories, Inc. | $6.88B | $226.93 | 0.30% | |
| BPMC | Blueprint Medicines Corporation | $6.42B | $101.35 | 1.66% | |
| MDGL | Madrigal Pharmaceuticals, Inc. | $6.33B | $275.26 | 1.97% | |
| BBIO | BridgeBio Pharma, Inc. | $6.32B | $34.25 | 2.64% | |
| HALO | Halozyme Therapeutics, Inc. | $6.06B | $56.07 | 2.45% | |
| GKOS | Glaukos Corporation | $5.31B | $94.29 | 0.61% | |
| TGTX | TG Therapeutics, Inc. | $5.30B | $35.11 | 1.68% | |
| AXSM | Axsome Therapeutics, Inc. | $5.20B | $105.16 | 0.50% | |
| IONS | Ionis Pharmaceuticals, Inc. | $5.18B | $33.51 | 0.15% | |
| GH | Guardant Health, Inc. | $5.10B | $40.62 | 5.37% | |
| NUVL | Nuvalent, Inc. | $5.07B | $74.61 | 0.20% | |
| ADMA | ADMA Biologics, Inc. | $4.75B | $19.84 | 0.35% | |
| NARI | Inari Medical, Inc. | $4.68B | $79.97 | 0.00% | |
| TMDX | TransMedics Group, Inc. | $4.14B | $127.12 | 0.45% | |
| PCVX | Vaxcyte, Inc. | $3.76B | $32.49 | 0.95% | |
| PTCT | PTC Therapeutics, Inc. | $3.75B | $48.52 | 0.76% | |
| KRYS | Krystal Biotech, Inc. | $3.72B | $125.96 | 0.28% | |
| SLNO | Soleno Therapeutics, Inc. | $3.69B | $73.35 | 3.00% | |
| CYTK | Cytokinetics, Incorporated | $3.64B | $31.02 | 0.96% | |
| RYTM | Rhythm Pharmaceuticals, Inc. | $3.63B | $61.33 | 0.89% | |
| SRPT | Sarepta Therapeutics, Inc. | $3.52B | $37.60 | 2.62% | |
| AMRX | Amneal Pharmaceuticals, Inc. | $3.49B | $7.32 | 0.27% | |
| SWTX | SpringWorks Therapeutics, Inc. | $3.48B | $46.71 | 0.06% | |
| RNA | Avidity Biosciences, Inc. | $3.40B | $30.98 | 2.27% | |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.27B | $34.03 | 2.85% | |
| ACLX | Arcellx, Inc. | $3.21B | $62.06 | 2.54% | |
| AKRO | Akero Therapeutics, Inc. | $3.19B | $49.65 | 3.37% | |
| SRRK | Scholar Rock Holding Corporation | $2.93B | $29.01 | 2.78% | |
| CPRX | Catalyst Pharmaceuticals, Inc. | $2.91B | $24.96 | 1.55% | |
| CRNX | Crinetics Pharmaceuticals, Inc. | $2.90B | $30.51 | 0.03% | |
| ACAD | ACADIA Pharmaceuticals Inc. | $2.88B | $21.57 | 3.23% | |
| PTGX | Protagonist Therapeutics, Inc. | $2.68B | $47.47 | 0.23% | |
| LEGN | Legend Biotech Corporation | $2.61B | $28.95 | 0.07% | |
| IMVT | Immunovant, Inc. | $2.33B | $14.85 | 0.27% | |
| APGE | Apogee Therapeutics, Inc. | $2.32B | $36.64 | 2.77% | |
| IBRX | ImmunityBio, Inc. | $2.25B | $2.66 | 2.31% | |
| MIRM | Mirum Pharmaceuticals, Inc. | $2.21B | $44.46 | 1.05% | |
| APLS | Apellis Pharmaceuticals, Inc. | $2.17B | $16.93 | 2.76% | |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.11B | $10.75 | 1.19% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $2.10B | $16.07 | 4.46% | |
| DNLI | Denali Therapeutics Inc. | $2.05B | $13.24 | 2.22% | |
| LGND | Ligand Pharmaceuticals Incorporated | $2.02B | $102.19 | 1.27% | |
| BHVN | Biohaven Ltd. | $1.99B | $14.81 | 0.47% | |
| HRMY | Harmony Biosciences Holdings, Inc. | $1.97B | $34.50 | 1.32% | |
| BLTE | Belite Bio, Inc | $1.94B | $64.87 | 1.17% | |
| KYMR | Kymera Therapeutics, Inc. | $1.93B | $29.64 | 2.02% | |
| TVTX | Travere Therapeutics, Inc. | $1.87B | $15.02 | 2.34% | |
| FOLD | Amicus Therapeutics, Inc. | $1.86B | $6.07 | 2.25% | |
| CGON | CG Oncology, Inc. Common stock | $1.85B | $25.62 | 2.33% | |
| BEAM | Beam Therapeutics Inc. | $1.82B | $15.83 | 3.00% | |
| TARS | Tarsus Pharmaceuticals, Inc. | $1.80B | $42.95 | 1.13% | |
| SUPN | Supernus Pharmaceuticals, Inc. | $1.78B | $31.70 | 0.06% | |
| TWST | Twist Bioscience Corporation | $1.77B | $29.30 | 1.42% | |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.74B | $4.18 | 6.07% | |
| SDGR | Schrödinger, Inc. | $1.73B | $21.62 | 0.84% | |
| AGIO | Agios Pharmaceuticals, Inc. | $1.66B | $32.09 | 0.79% | |
| ARQT | Arcutis Biotherapeutics, Inc. | $1.65B | $13.04 | 4.61% | |
| IRON | Disc Medicine, Inc. | $1.58B | $46.68 | 0.41% | |
| LQDA | Liquidia Corporation | $1.50B | $14.92 | 0.53% | |
| IDYA | IDEAYA Biosciences, Inc. | $1.49B | $19.89 | 0.80% | |
| ADPT | Adaptive Biotechnologies Corporation | $1.41B | $9.52 | 2.26% | |
| MNKD | MannKind Corporation | $1.40B | $4.15 | 0.73% | |
| JANX | Janux Therapeutics, Inc. | $1.38B | $23.80 | 1.00% | |
| ANIP | ANI Pharmaceuticals, Inc. | $1.34B | $58.72 | 0.79% | |
| DYN | Dyne Therapeutics, Inc. | $1.34B | $11.96 | 2.29% | |
| CLDX | Celldex Therapeutics, Inc. | $1.31B | $19.78 | 0.30% | |
| AZTA | Azenta, Inc. | $1.28B | $26.72 | 2.23% | |
| AORT | Artivion, Inc. | $1.23B | $29.58 | 0.44% | |
| GRAL | GRAIL, Inc. | $1.19B | $38.41 | 6.54% |